Target Price Playground

GSK
$47.76
Swing & Horizon Engine Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on GSK? Launch with your exact active legs & +12.0% target.

๐Ÿ“‹ Strategy

Moderately bullish. Debit, capped max profit + loss.

๐ŸŽฏ Target

1-Click Institutional Target Anchors:
56d from today

โš™๏ธ Legs

LONG CALL ยท $48 ยท Jan '27
Qty 1 ยท Premium $2.28 ยท ฮ” 0.53
SHORT CALL ยท $52 ยท Jan '27
Qty 1 ยท Premium $0.88 ยท ฮ” 0.27
P&L at Expiry Now $48 Target $53 $33 $48 $62
Stock (100 sh) Bull Call Spread Now Target
๐Ÿ’ก Stock vs Options at Target

If GSK hits $53 by Jan 15: the bull call spread returns +$260 (186.2%) on $140 risked, vs +$573 (12.0%) for 100 shares on $4,776. Options give 15.5ร— capital efficiency.

๐Ÿ“… Expiry & Gamma Wall Alignment

Options expire Jan 15, 2027 (56 days out). P&L shown is the value at expiry if GSK is at $53.

๐Ÿ“Š Projected Return

P&L if GSK hits $53 by Jan 15
+$260
+186.2% on $140 risked
Max Profit
+$260
If the stock โ‰ฅ $52 at expiry
Max Loss
โˆ’$140
Net debit
Break-even
$49.40
+3.43% from spot
Prob. of Profit at Expiry (PoP)
38.7%
Above breakeven ($49.40) ยท Touch Target: 31%
30-Day Theta Burn (If Flat)
โˆ’$14
10.0% of entry cost ยท Daily ฮ˜: $-0.46/day
Net ฮ” / ฮ˜ / V
25.77 / -0.46 / 1.23
per spread, per $1 move / day / vol pt
๐Ÿ’พ Log in to save ๐Ÿ“Š My Saved Strategies

๐Ÿ“Š P&L Scenarios โ€” what happens at different prices and dates

GSK Price Today +3d (Nov 23) +7d (Nov 27) Dec 8 Dec 27 Jan 15 (exp)
$38 (-20%) -$135 -$136 -$137 -$139 -$140 -$140
$41 (-15%) -$124 -$125 -$127 -$133 -$139 -$140
$43 (-10%) -$99 -$101 -$104 -$114 -$133 -$140
$45 (-5%) -$57 -$59 -$63 -$74 -$104 -$140
$47 (-2%) -$24 -$26 -$29 -$39 -$68 -$140
$48 (0%) โ† spot -$0 -$1 -$4 -$11 -$34 -$140
$49 (+2%) +$25 +$24 +$23 +$19 +$4 -$68
$50 (+5%) +$63 +$63 +$64 +$65 +$67 +$75
$53 (+10%) +$123 +$125 +$127 +$136 +$161 +$260
$53 (+12%) โ† target +$144 +$146 +$149 +$160 +$190 +$260
$55 (+15%) +$172 +$174 +$178 +$190 +$221 +$260
$57 (+20%) +$207 +$210 +$213 +$225 +$248 +$260
Uses GSK's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.